Maintenance Therapy Post-Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia

High-risk acute myeloid leukemia has been associated with a poor outcome. Hematopoietic stem cell transplantation (HSCT) represents the only curative option for eligible patients. Relapse after HSCT is a dramatic event with poor chances of survival. With the aim of reducing the rate of post-HSCT rel...

Full description

Saved in:
Bibliographic Details
Main Authors: Martina Canichella, Matteo Molica, Carla Mazzone, Paolo de Fabritiis
Format: Article
Language:English
Published: MDPI AG 2024-10-01
Series:Current Oncology
Subjects:
Online Access:https://www.mdpi.com/1718-7729/31/10/451
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850205102184333312
author Martina Canichella
Matteo Molica
Carla Mazzone
Paolo de Fabritiis
author_facet Martina Canichella
Matteo Molica
Carla Mazzone
Paolo de Fabritiis
author_sort Martina Canichella
collection DOAJ
description High-risk acute myeloid leukemia has been associated with a poor outcome. Hematopoietic stem cell transplantation (HSCT) represents the only curative option for eligible patients. Relapse after HSCT is a dramatic event with poor chances of survival. With the aim of reducing the rate of post-HSCT relapse, maintenance treatment has been investigated in this setting. Results from clinical trials suggest an advantage in the use of a maintenance strategy; however, standardized guidelines are not yet available due to the lack of prospective clinical trials. In this review, we have reported the most important strategies adopted as post-HSCT maintenance, highlighting their efficacy, but the current research also opens questions.
format Article
id doaj-art-7d2a0582d8b74d75be61630a44c107e4
institution OA Journals
issn 1198-0052
1718-7729
language English
publishDate 2024-10-01
publisher MDPI AG
record_format Article
series Current Oncology
spelling doaj-art-7d2a0582d8b74d75be61630a44c107e42025-08-20T02:11:09ZengMDPI AGCurrent Oncology1198-00521718-77292024-10-0131106050606010.3390/curroncol31100451Maintenance Therapy Post-Hematopoietic Stem Cell Transplantation in Acute Myeloid LeukemiaMartina Canichella0Matteo Molica1Carla Mazzone2Paolo de Fabritiis3Hematology, St. Eugenio Hospital, ASL Roma2, 00144 Rome, ItalyDepartment of Hematology-Oncology, Azienda Ospedaliera Pugliese-Ciaccio, 88100 Catanzaro, ItalyHematology, St. Eugenio Hospital, ASL Roma2, 00144 Rome, ItalyHematology, St. Eugenio Hospital, ASL Roma2, 00144 Rome, ItalyHigh-risk acute myeloid leukemia has been associated with a poor outcome. Hematopoietic stem cell transplantation (HSCT) represents the only curative option for eligible patients. Relapse after HSCT is a dramatic event with poor chances of survival. With the aim of reducing the rate of post-HSCT relapse, maintenance treatment has been investigated in this setting. Results from clinical trials suggest an advantage in the use of a maintenance strategy; however, standardized guidelines are not yet available due to the lack of prospective clinical trials. In this review, we have reported the most important strategies adopted as post-HSCT maintenance, highlighting their efficacy, but the current research also opens questions.https://www.mdpi.com/1718-7729/31/10/451acute myeloid leukemia (AML)hematopoietic stem cell transplantation (HSCT)maintenance therapy post-HSCT in AMLtargeted drugscellular therapyhypometylating agents
spellingShingle Martina Canichella
Matteo Molica
Carla Mazzone
Paolo de Fabritiis
Maintenance Therapy Post-Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia
Current Oncology
acute myeloid leukemia (AML)
hematopoietic stem cell transplantation (HSCT)
maintenance therapy post-HSCT in AML
targeted drugs
cellular therapy
hypometylating agents
title Maintenance Therapy Post-Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia
title_full Maintenance Therapy Post-Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia
title_fullStr Maintenance Therapy Post-Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia
title_full_unstemmed Maintenance Therapy Post-Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia
title_short Maintenance Therapy Post-Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia
title_sort maintenance therapy post hematopoietic stem cell transplantation in acute myeloid leukemia
topic acute myeloid leukemia (AML)
hematopoietic stem cell transplantation (HSCT)
maintenance therapy post-HSCT in AML
targeted drugs
cellular therapy
hypometylating agents
url https://www.mdpi.com/1718-7729/31/10/451
work_keys_str_mv AT martinacanichella maintenancetherapyposthematopoieticstemcelltransplantationinacutemyeloidleukemia
AT matteomolica maintenancetherapyposthematopoieticstemcelltransplantationinacutemyeloidleukemia
AT carlamazzone maintenancetherapyposthematopoieticstemcelltransplantationinacutemyeloidleukemia
AT paolodefabritiis maintenancetherapyposthematopoieticstemcelltransplantationinacutemyeloidleukemia